Bio Usawa’s CEO and President, Dr. Menghis Bairu, will speak on two key panels at the East Africa Pharma
& Biotech (EAPB) 2025 Conference.

10:40 – 11:50 AM CAT: Strengthening Local Pharmaceutical Manufacturing Capacity
1:55 – 3:15 PM CAT: Nurturing a Sustainable Pharma & Biotech Value Chain in Africa

To book a meeting with Dr. Menghis at EAPB 2025, reach out via [email protected] or send us a message on LinkedIn.

About Bio Usawa

Bio Usawa is Africa’s pioneering biotechnology company dedicated to democratizing access to life-saving biotherapeutics. Headquartered in Kigali, Rwanda, the company develops, licenses, and manufactures affordable monoclonal antibodies and biosimilars targeting cancer, diabetes complications, infectious diseases, and autoimmune conditions.